Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgical Innovations GroupLSE:SUN Days Payable is 54.16 as of Dec. 2025, which is 3% below its 10-year median of 55.57. The stock has 2 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Surgical Innovations Group ranks worse than 64.36% on this metric.
The historical rank and industry rank for Surgical Innovations Group's Days Payable or its related term are showing as below:
LSE:SUN'
s Days Payable Range Over the Past 10 Years
Min: 29.22 Med: 55.57 Max: 64.06
Current: 52.71
During the past 13 years, Surgical Innovations Group's highest Days Payable was 64.06. The lowest was 29.22. And the median was 55.57.
LSE:SUN's Days Payable is ranked worse than 64.36% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs LSE:SUN: 52.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surgical Innovations Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's Days Payable falls into.
Surgical Innovations Group Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group (LSE:SUN) has a Days Payable of 54.16 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surgical Innovations Group and its competitors. This is near median its historical median of 55.57. Over the past decade, Surgical Innovations Group's Days Payable has ranged from 29.22 to 64.06. According to the industry distribution chart, Surgical Innovations Group ranks #511 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 64.4%.
Is Surgical Innovations Group's Days Payable too high?
Surgical Innovations Group's current Days Payable of 54.16 is near median its 10-year median of 55.57. Over the past 10 years, this metric has ranged from a low of 29.22 to a high of 64.06. The Medical Devices & Instruments industry median Days Payable is 67.85. Surgical Innovations Group's value of 54.16 is 20.2% below this industry median. Based on the distribution chart, Surgical Innovations Group ranks #511 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Surgical Innovations Group's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #511 out of 794 companies for Days Payable. This places Surgical Innovations Group in the lower half of its industry. The industry median Days Payable is 67.85. Surgical Innovations Group's value of 54.16 is 20.2% below this benchmark. Historically, Surgical Innovations Group's own Days Payable has ranged from 29.22 to 64.06 over the past decade. While the company's 10-year median is 55.57 vs. the industry median of 67.85, Surgical Innovations Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current Days Payable of 54.16 is 20.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current Days Payable is 54.16, which is near median its own 10-year median of 55.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Surgical Innovations Group (LSE:SUN) has a current Days Payable of 54.16. The current Days Payable is 54.16, which is near median its 10-year median of 55.57 and 20.2% below the Medical Devices & Instruments industry median of 67.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current Days Payable is 54.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 
